Patents Represented by Attorney Max D. Hensely

Find this attorney in the Justia Lawyer Directory

  • Therapeutic method for activating factor VII
    Patent number: 4456591
    Abstract: Patients having a clotting factor defect can be successfully treated by the administration of a composition containing effective hemostatic amounts of factor VIIa. Preferably, the factor VIIa is substantially free of factors IXa and Xa. Procedures for preparing the above therapeutic compositions are also described. A method involving the activation of factor VII is set forth.
    Type: Grant
    Filed: November 29, 1982
    Date of Patent: June 26, 1984
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventor: William R. Thomas